Aveo Pharmaceuticals, Inc.

CIK 1325879 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Aveo Pharmaceuticals, Inc..

Recent SEC filings

FiledFormAccession number
Jan 30, 202315-12G0001193125-23-019075
Jan 23, 2023EFFECT9999999995-23-000154
Jan 23, 2023EFFECT9999999995-23-000155
Jan 23, 2023EFFECT9999999995-23-000156
Jan 19, 2023POS AM0001193125-23-011020
Jan 19, 202340000899243-23-002183
Jan 19, 202340000899243-23-002184
Jan 19, 2023S-8 POS0001193125-23-011007
Jan 19, 202340000899243-23-002193
Jan 19, 2023S-8 POS0001193125-23-010998
Jan 19, 2023POS AM0001193125-23-011018
Jan 19, 202340000899243-23-002195
Jan 19, 202325-NSE0001354457-23-000029
Jan 19, 20238-K0001193125-23-010990
Jan 19, 202340000899243-23-002191
Jan 19, 2023S-8 POS0001193125-23-011011
Jan 19, 202340000899243-23-002186
Jan 19, 202340000899243-23-002192
Jan 19, 2023S-8 POS0001193125-23-010996
Jan 19, 202340000899243-23-002190
Jan 19, 202340000899243-23-002188
Jan 19, 2023POS AM0001193125-23-011016
Jan 19, 2023S-8 POS0001193125-23-011000
Jan 19, 2023S-8 POS0001193125-23-011009
Jan 19, 202340000899243-23-002182